Quantcast
HomeSearch

pharma - search results

If you're not happy with the results, please do another search.

Big Pharma’s Johnson & Johnson under investigation in South Africa over ‘excessive’ drug prices

Headline Health -
CAPE TOWN, South Africa (AP) — U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging "excessive" prices for...

CVS and Walgreens plan to sell abortion pill mifepristone at pharmacies after FDA rule change

Headline Health -
CNBC – Walgreens and CVS will sell the prescription abortion pill mifepristone after the Food and Drug Administration this week dropped a long-standing rule...

Biden’s FDA Greenlights Pharmacies to Peddle Abortion Pills

Headline Health -
(Mark Pellin, Headline USA) In yet another attempt to circumvent the Supreme Court’s overturning of Roe v. Wade, the Biden administration’s Food and Drug...

As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing Stronger

Headline Health -
Common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics are troubling infectious disease specialists.

Crony Capitalists Cash In On Deep State/Big Pharma Revolving Door

Headline Health -
HEADLINE HEALTH – The free flow of key personnel between US regulatory agencies and the corporations they oversee is well known. These personnel often hold...

Which Companies Aren’t Exiting Russia? Big Pharma

Headline Health -
Even as the war in Ukraine has prompted an exodus of international companies from Russia, U.S. and global drug companies said they would continue manufacturing and selling their products there.

Big Pharma’s Chokehold On Diabetics Is About To End

Headline Health -
Civica Rx, a non-profit generic drug maker, has announced that it plans to manufacture and sell insulin for no more than $30 a vial. It is expected to be available as soon as early 2024, pending federal approval.

Big Pharma Overcharges Men 400% For Prostate Drug Developed At Taxpayer Expense

Headline Health -
LOS ANGELES TIMES – Xtandi, a wonder drug for prostate cancer, was developed at UCLA with substantial funding from the taxpayers through the Pentagon...

Seeking Refills: Aging Pharmacists Leave Drugstores Vacant in Rural America

Headline Health -
Pharmacies were once routinely bequeathed from one generation to the next, but, in interviews with more than a dozen pharmacists, many said the pressure of running an independent drugstore have them pushing their offspring toward other careers.

Big Pharma Fast-Tracks Omicron Vaccines

Headline Health -
The World Health Organization on Friday said the new strain, named omicron, is a “variant of concern” that may pose a higher risk of reinfection than past mutations of the virus. Pfizer and BioNTech said they are investigating omicron, first labeled B.1.1.529, and can adapt their vaccine quickly if needed.
123...42Page 2 of 42

Most Popular

Load more

Recent Comments

RESOURCES
Subscribe to Headline Health
Not Receiving Our Emails?
Unsubscribe/Update Email
Privacy Policy
Comment Policy
Terms of Service
Material Connection Disclosure
RSS
Accessibility

CONTACT US
Advertise with Headline Health
Contact Us
Digital Millennium Copyright Act (DMCA)

HEADLINE HEALTH • PO BOX 49043 • CHARLOTTE, NC 28277

THE INFORMATION PRESENTED HERE IS FOR GENERAL EDUCATIONAL PURPOSES ONLY. YOU SHOULD ALWAYS CONSULT WITH YOUR PERSONAL PHYSICIAN REGARDING ANY PERSONAL HEALTH PROBLEM, AND YOU SHOULD ALWAYS CONSULT WITH YOUR FINANCIAL ADVISER REGARDING INVESTMENT DECISIONS. FDA DISCLOSURE: THE STATEMENTS, ARTICLES, AND PRODUCTS FEATURED IN HEADLINE HEALTH EMAILS AND AT HEADLINEHEALTH.COM HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. NO INFORMATION OR PRODUCTS APPEARING IN EMAILS OR THE WEBSITE ARE INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. MATERIAL CONNECTION DISCLOSURE: HEADLINE HEALTH MAY HAVE AN AFFILIATE RELATIONSHIP AND/OR ANOTHER MATERIAL CONNECTION TO ANY PERSONS OR BUSINESSES MENTIONED IN OR LINKED TO FROM EMAILS OR THE WEBSITE AND MAY RECEIVE COMMISSIONS FROM PURCHASES YOU MAKE ON SUBSEQUENT WEB SITES. YOU SHOULD NOT RELY SOLELY ON INFORMATION PUBLISHED BY HEADLINE HEALTH TO EVALUATE THE PRODUCT OR SERVICE BEING OFFERED. ALWAYS EXERCISE YOUR OWN DUE DILIGENCE BEFORE PURCHASING ANY PRODUCT OR SERVICE.

Copyright 2023 HEADLINEHEALTH.COM